- Home
- CIF vs CCEL Comparison
CIF vs CCEL Comparison
Compare CIF & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIF
- CCEL
- Stock Information
- Founded
- CIF 1988
- CCEL 1989
- Country
- CIF United States
- CCEL United States
- Employees
- CIF N/A
- CCEL N/A
- Industry
- CIF Trusts Except Educational Religious and Charitable
- CCEL Managed Health Care
- Sector
- CIF Finance
- CCEL Health Care
- Exchange
- CIF Nasdaq
- CCEL Nasdaq
- Market Cap
- CIF 31.9M
- CCEL 34.8M
- IPO Year
- CIF N/A
- CCEL 1997
- Fundamental
- Price
- CIF N/A
- CCEL $4.48
- Analyst Decision
- CIF
- CCEL Strong Buy
- Analyst Count
- CIF 0
- CCEL 1
- Target Price
- CIF N/A
- CCEL $8.50
- AVG Volume (30 Days)
- CIF 43.9K
- CCEL 19.7K
- Earning Date
- CIF 01-01-0001
- CCEL 10-15-2025
- Dividend Yield
- CIF 10.11%
- CCEL 13.39%
- EPS Growth
- CIF N/A
- CCEL N/A
- EPS
- CIF N/A
- CCEL N/A
- Revenue
- CIF N/A
- CCEL $31,988,783.00
- Revenue This Year
- CIF N/A
- CCEL $1.75
- Revenue Next Year
- CIF N/A
- CCEL N/A
- P/E Ratio
- CIF N/A
- CCEL N/A
- Revenue Growth
- CIF N/A
- CCEL 1.10
- 52 Week Low
- CIF $1.47
- CCEL $4.09
- 52 Week High
- CIF $1.77
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- CIF 51.17
- CCEL N/A
- Support Level
- CIF $1.74
- CCEL N/A
- Resistance Level
- CIF $1.79
- CCEL N/A
- Average True Range (ATR)
- CIF 0.03
- CCEL 0.00
- MACD
- CIF -0.00
- CCEL 0.00
- Stochastic Oscillator
- CIF 38.12
- CCEL 0.00
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.